Dhampur Bio Organics Board Approves FY26 Results, Dividend & Acquisition
Dhampur Bio Organics approved audited FY26 results and recommended a dividend of ₹1.50 per share. The company will acquire Sonitron Chemicals, re-designate Gautam Goel as Chairman & CEO, and re-appoint auditors. The AGM is scheduled for July 24, 2026.
The outcome of the board meeting involves significant corporate actions including financial results, dividend payout, a strategic acquisition, and key management changes, which are material for investors and the company's future outlook.
The announcement includes approval of financial results, recommendation of a dividend, acquisition of another company, and key management re-designations, all of which are generally positive developments for the company.
Dhampur Bio Organics Limited announced the outcome of its Board Meeting held on May 30, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A dividend of ₹1.50 per equity share for the financial year ended March 31, 2026, was recommended, subject to shareholder approval, with a record date set for July 17, 2026.
The company also approved amendments to its Articles of Association to enable the appointment of the Managing Director and/or Chief Executive Officer as Chairman, subject to shareholder approval. Mr. Gautam Goel has been re-designated as Chairman and Chief Executive Officer effective May 31, 2026, pending shareholder approval. Additionally, revisions in remuneration for Ms. Maayashree Goel and Ms. Meerashree Goel were approved, subject to shareholder consent.
Further, the Board approved the acquisition of Sonitron Chemicals Private Limited. M/s Mittal Gupta & Company were re-appointed as Statutory Auditors for a second five-year term, and Mr. S.R. Kapur was re-appointed as Cost Auditor for the financial year 2026-27, both subject to shareholder approval. The recommended commission for Non-Executive Directors for FY2025-26 was also approved, pending shareholder consent.
The company also proposed to convene its 6th Annual General Meeting on July 24, 2026. The audited financial results will be published in newspapers as per listing regulations. The Board meeting commenced at 11:10 AM IST and concluded at 11:45 AM IST.
What to do with a filing like this
Dhampur Bio Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dhampur Bio Organics Limited. Read the original for the full detail.